250 related articles for article (PubMed ID: 10964046)
21. Treatment delays in oral cavity squamous cell carcinoma and association with survival.
Fujiwara RJ; Judson BL; Yarbrough WG; Husain Z; Mehra S
Head Neck; 2017 Apr; 39(4):639-646. PubMed ID: 28236349
[TBL] [Abstract][Full Text] [Related]
22. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
[TBL] [Abstract][Full Text] [Related]
23. p53 mutation is rare in oral mucosa brushings from patients previously treated for a head and neck squamous cell carcinoma.
Acha-Sagredo A; Ruesga MT; Rodriguez C; Aguirregaviria JI; de Pancorbo MM; Califano JA; Aguirre JM
Oral Oncol; 2009 Aug; 45(8):661-4. PubMed ID: 19027352
[TBL] [Abstract][Full Text] [Related]
24. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Girod SC; Pfeiffer P; Ries J; Pape HD
Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
[TBL] [Abstract][Full Text] [Related]
25. Gene therapy for head and neck cancer.
Frank DK
Surg Oncol Clin N Am; 2002 Jul; 11(3):589-606, vi-vii. PubMed ID: 12492081
[TBL] [Abstract][Full Text] [Related]
26. Tumor-related markers in histologically normal margins correlate with locally recurrent oral squamous cell carcinoma: a retrospective study.
Wang X; Chen S; Chen X; Zhang C; Liang X
J Oral Pathol Med; 2016 Feb; 45(2):83-8. PubMed ID: 26260282
[TBL] [Abstract][Full Text] [Related]
27. The prognostic impact of micrometastases and isolated tumor cells in early oral squamous cell carcinoma.
de Bree R; Witjes MJH; de Keizer B
Eur Arch Otorhinolaryngol; 2021 Dec; 278(12):5105-5106. PubMed ID: 33386440
[No Abstract] [Full Text] [Related]
28. Aurora sheds light on head and neck squamous cell carcinoma.
Han H; Von Hoff DD
Clin Cancer Res; 2006 Sep; 12(17):5003-4. PubMed ID: 16951211
[No Abstract] [Full Text] [Related]
29. Clues toward precision medicine in oral squamous cell carcinoma: utility of next-generation sequencing for the prognostic stratification of high-risk patients harboring neck lymph node extracapsular extension.
Wang HM; Liao CT; Yen TC; Chen SJ; Lee LY; Hsieh CH; Lin CY; Ng SH
Oncotarget; 2016 Sep; 7(39):63082-63092. PubMed ID: 27590518
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic factors for head and neck cancer].
Fujieda S
Gan To Kagaku Ryoho; 2001 Apr; 28(4):440-7. PubMed ID: 11329776
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic and prognostic relevance of expression of human telomerase subunits in oral cancer.
Lee BK; Diebel E; Neukam FW; Wiltfang J; Ries J
Int J Oncol; 2001 Nov; 19(5):1063-8. PubMed ID: 11605010
[TBL] [Abstract][Full Text] [Related]
32. Oral squamous cell carcinoma overview.
Scully C; Bagan J
Oral Oncol; 2009; 45(4-5):301-8. PubMed ID: 19249237
[No Abstract] [Full Text] [Related]
33. Oral squamous cell carcinoma - progresses from risk assessment to treatment.
Mao L
Chin J Dent Res; 2012; 15(2):83-8. PubMed ID: 23509828
[TBL] [Abstract][Full Text] [Related]
34. Head and neck cancer and precancer: can we use molecular genetics to make better predictions?
Partridge M
Ann R Coll Surg Engl; 1999 Jan; 81(1):1-11. PubMed ID: 10325677
[No Abstract] [Full Text] [Related]
35. Cytogenetic significance of chromosome 17 aberrations and P53 gene mutations as prognostic markers in oral squamous cell carcinoma.
Zedan W; Mourad MI; El-Aziz SM; Salamaa NM; Shalaby AA
Diagn Pathol; 2015 Feb; 10():2. PubMed ID: 25881131
[TBL] [Abstract][Full Text] [Related]
36. A combined lymphokine-activated killer (LAK) cell immunotherapy and adenovirus-p53 gene therapy for head and neck squamous cell carcinoma.
Saito H; Ando S; Morishita N; Lee KM; Dator D; Dy D; Shigemura K; Adhim Z; Nibu K; Fujisawa M; Shirakawa T
Anticancer Res; 2014 Jul; 34(7):3365-70. PubMed ID: 24982341
[TBL] [Abstract][Full Text] [Related]
37. Cancer of the upper aerodigestive tract. Basic principles and concepts.
McGuirt WF
Postgrad Med; 1986 Jul; 80(1):77-84, 93, 96. PubMed ID: 3725718
[TBL] [Abstract][Full Text] [Related]
38. Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma.
Xia W; Lau YK; Zhang HZ; Liu AR; Li L; Kiyokawa N; Clayman GL; Katz RL; Hung MC
Clin Cancer Res; 1997 Jan; 3(1):3-9. PubMed ID: 9815530
[TBL] [Abstract][Full Text] [Related]
39. p53 mutation and locoregional treatment failure in head and neck squamous cell carcinoma.
Koch WM; Brennan JA; Zahurak M; Goodman SN; Westra WH; Schwab D; Yoo GH; Lee DJ; Forastiere AA; Sidransky D
J Natl Cancer Inst; 1996 Nov; 88(21):1580-6. PubMed ID: 8901856
[TBL] [Abstract][Full Text] [Related]
40. Human immunodeficiency virus-associated squamous cell carcinomas of the head and neck presenting as oral and primary intraosseous squamous cell carcinomas.
Langford A; Langer R; Lobeck H; Stolpmann HJ; Pohle HD; Reichart P; Bier J
Quintessence Int; 1995 Sep; 26(9):635-54. PubMed ID: 8602445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
